Resultados de la búsqueda 1471-1480 of 6482 for Receptor

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  2. Ensayos clínicos - Neurología

    Rochester, Minn. The purpose of this post-approval study is to further evaluate the long-term safety and effectiveness of Medtronic DBS therapy for epilepsy on ...

  3. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia ...

  4. Neurología - Ensayos clínicos

    The overall goal of PPMI is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability. PLS ...

  5. Oncología (médica) - Ensayos clínicos

    ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation (ORACLE). Rochester, Minn. The purpose of ORACLE is to demonstrate the ability of a novel ...

  6. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to compare the effect of adding nivolumab to the usual chemotherapy (cisplatin or carboplatin with gemcitabine) versus the ...

  7. Oncología (médica) - Ensayos clínicos

    This protocol is being designed to offer testicular tissue cryopreservation to male pediatric patients (0-17 years of age) with fertility threatening medical ...

  8. Neurología - Ensayos clínicos

    The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...

  9. Oncología (médica) - Ensayos clínicos

    Jacksonville, Fla. The purpose of this study is to compare the effects on low-risk breast cancer receiving usual care that includes regional radiation therapy, ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...